Toronto - Delayed Quote CAD
BriaCell Therapeutics Corp. (BCT.TO)
8.45
+1.33
+(18.68%)
At close: 4:00:01 PM EDT
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-21,994.86
-24,126.13
-23,744.86
-12,484.38
-7,750.19
Investing Cash Flow
-831.80
-681.80
--
--
--
Financing Cash Flow
21,595.79
4,418.93
3,954.30
-3,742.66
64,997.62
End Cash Position
5,013.65
862.09
21,251.09
41,041.65
57,268.69
Capital Expenditure
--
-456.80
--
--
--
Issuance of Capital Stock
20,774.77
4,418.93
4,000
--
51,622.34
Issuance of Debt
--
--
--
--
215.71
Repayment of Debt
--
--
--
--
-546.11
Repurchase of Capital Stock
--
--
-47.29
-10,171.73
--
Free Cash Flow
-22,451.66
-24,582.93
-23,744.86
-12,484.38
-7,750.19
7/31/2021 - 8/13/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ONC.TO Oncolytics Biotech Inc.
0.8100
-3.57%
MDNA.TO Medicenna Therapeutics Corp.
1.0500
0.00%
ASEP.CN ASEP Medical Holdings Inc.
0.5000
0.00%
NRXBF NUREXONE BIOLOGIC INC
0.4920
+1.30%
XRTX.V XORTX Therapeutics Inc.
1.4500
+0.69%
VXL.V Vaxil Bio Ltd.
0.0100
0.00%
ONCO.CN Onco-Innova
1.4500
+2.11%
MEIP MEI Pharma, Inc.
2.1550
+8.84%
MSCL.TO Satellos Bioscience Inc.
0.6600
+6.45%
ACTU Actuate Therapeutics, Inc. Common stock
9.04
+0.44%